Examining Parkinson's Disease-Related Retirement: Results of Turkey

Parkinson Disease Clinical Trial

Official title:

Examining Parkinson's Disease-Related Retirement: Results of Turkey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03779880
• Other study ID #: 132
• Status: Completed
• Start date: May 2, 2018
• Est. completion date: March 28, 2019

Study information

• Verified date: September 2019
• Source: Istanbul Kültür University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Although Parkinson Disease's (PD) is usually associated with an older patient population, 5% of patients are diagnosed at age 50 and 30% before 65 years of age. This shows that many patients with PD have diagnosed during the active study and have long periods of normal retirement. After the diagnosis of Parkinson's patients, the duration of leaving of employment vary between 0 and 25 years. It was found that patients' full-time working capacity decreased by up to 80% and they quitted earlier than the general population. The disability associated with PD is thought to be a factor in this situation. Nevertheless, the reasons for early retirement are not fully known and more information is needed on the specific problems of PD in order for patients to continue their career. The aim of our study is to examine the impact of Parkinson's disease on retirement and to contribute to Turkey's data. Patients with PD admitted to the Parkinson's disease outpatient clinic, which is the biggest clinic of Turkey about neurology, are included in the study. It is planned to meet with 75 patients on 31/12/2018 and to reach the end of the data collection phase.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: March 28, 2019
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 85 Years

Eligibility

Inclusion Criteria:

• To be between 30-85 aged

• Parkinson Disease diagnosis according to the United Kingdom Brain Bank criteria

• To be treated with antiparkinson

Exclusion Criteria:

• Dementia

• Severe cognitive impairment

• Not willing to participate in the study

Related Conditions & MeSH terms

• Parkinson Disease

Locations

Country	Name	City	State
Turkey	Istanbul Cerrahpasa University	Istanbul

Sponsors (3)

Lead Sponsor	Collaborator
Istanbul Kültür University	Istanbul University, Marmara University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative interview	The researcher conducted interviews to find out about things that could not be directly observed. Interviews have been done face to face and used to collect personal experiences about Parkinson Disease and work life.	The researcher interviewed for about half an hour at once time with each participant.